Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Vellas

Showing results (31-40 of 697) with videos related to

Pageof 70
Sort By:
Journal of Alzheimer'S Disease : JAD|October 28, 2008
Disease modifying trials in Alzheimer's disease: perspectives for the futureBruno Vellas, Nicola Coley, Sandrine Andrieu
Nestle Nutrition Institute Workshop Series|November 7, 2015
Nutrition, Frailty, Cognitive Frailty and Prevention of Disabilities with AgingSophie Guyonnet, Marion Secher, Bruno Vellas
Journal of the American Geriatrics Society|May 16, 2014
Overtreating the numbers may have unfortunate consequencesMatthieu Lilamand, Bruno Vellas, Matteo Cesari
The Lancet. Neurology|October 18, 2025
Multidomain lifestyle interventions for cognitive functionSandrine Andrieu, Nicola Coley, Bruno Vellas
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "The Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, 2006."Bruno Vellas, Emma Reynish, Philippe Robert
Experimental Gerontology|October 30, 2012
The stress of agingMatteo Cesari, Bruno Vellas, Giovanni Gambassi
BMJ (Clinical Research Ed.)|October 10, 2020
Alzheimer's disease beyond amyloid: strategies for future therapeutic interventionsJiong Shi, Marwan N Sabbagh, Bruno Vellas
Soins; La Revue De Reference Infirmiere|June 24, 2004
[Clinical aspects of dementia and specificity of Alzheimer's disease]Laurent Balardy, Pierre-Jean Ousset, Bruno Vellas
Nature Reviews. Drug Discovery|March 16, 2013
Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's diseasePaul S Aisen, Bruno Vellas, Harald Hampel
Expert Opinion on Biological Therapy|May 16, 2012
Gantenerumab for the treatment of Alzheimer's diseaseJulien Delrieu, Pierre Jean Ousset, Bruno Vellas
Pageof 70

Showing results (31-40 of 697) with videos related to

Sort By:
Pageof 70
Journal of Alzheimer'S Disease : JAD|October 28, 2008
Disease modifying trials in Alzheimer's disease: perspectives for the futureBruno Vellas, Nicola Coley, Sandrine Andrieu
Nestle Nutrition Institute Workshop Series|November 7, 2015
Nutrition, Frailty, Cognitive Frailty and Prevention of Disabilities with AgingSophie Guyonnet, Marion Secher, Bruno Vellas
Journal of the American Geriatrics Society|May 16, 2014
Overtreating the numbers may have unfortunate consequencesMatthieu Lilamand, Bruno Vellas, Matteo Cesari
The Lancet. Neurology|October 18, 2025
Multidomain lifestyle interventions for cognitive functionSandrine Andrieu, Nicola Coley, Bruno Vellas
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "The Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, 2006."Bruno Vellas, Emma Reynish, Philippe Robert
Experimental Gerontology|October 30, 2012
The stress of agingMatteo Cesari, Bruno Vellas, Giovanni Gambassi
BMJ (Clinical Research Ed.)|October 10, 2020
Alzheimer's disease beyond amyloid: strategies for future therapeutic interventionsJiong Shi, Marwan N Sabbagh, Bruno Vellas
Soins; La Revue De Reference Infirmiere|June 24, 2004
[Clinical aspects of dementia and specificity of Alzheimer's disease]Laurent Balardy, Pierre-Jean Ousset, Bruno Vellas
Nature Reviews. Drug Discovery|March 16, 2013
Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's diseasePaul S Aisen, Bruno Vellas, Harald Hampel
Expert Opinion on Biological Therapy|May 16, 2012
Gantenerumab for the treatment of Alzheimer's diseaseJulien Delrieu, Pierre Jean Ousset, Bruno Vellas
Pageof 70